Active ingredients: dactinomycin (actinomycin d)
What it is used for
Wilm's Tumour; Rhabdomyosarcoma; Carcinoma of the Testes and Uterus. Other Neoplasms: Actinomycin D given IV or by regional perfusion, either alone or with other antineoplastic compounds or with X-ray therapy in the palliative treatment of Ewing's sarcoma and sarcoma botryoides; non-metastatic Ewing's carcinoma. Actinomyin D and Radiation therapy; Actinomycin D in various types of sarcoma, carcinoma and adenocarcinoma using isolation-perfusion technique. FOR FULL LIST OF INDICATIONS REFER TO APPROVED PI DOCUMENT.
How to take it
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 25 degrees Celsius
- Shelf lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Yellow lyophilized powder
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient dactinomycin (actinomycin d)
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems